Trials / Suspended
SuspendedNCT00048529
Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus
- Status
- Suspended
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 70 (planned)
- Sponsor
- Tularik · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a clinical research study of T900607-sodium to determine if it is effective and safe in treating gastric cancer and adenocarcinoma of the esophagus. Patients will be treated on a weekly basis with an intravenous injection of the study drug.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | T900607-sodium intravenous |
Timeline
- Start date
- 2002-09-01
- First posted
- 2002-11-04
- Last updated
- 2005-06-24
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00048529. Inclusion in this directory is not an endorsement.